Skip to main content
Search

McMaster University

5 related articles

Subscribe to updates
  1. arXiv

    In federated learning with missing modalities, the server should count prediction support: RASO lifts KU-HAR from 41.30 to 49.13 under concatenation

    In multimodal federated learning, when clients observe only some modalities, aggregating by which modality is available drops encoders that still shape predictions. RASO instead picks each component's contributors by prediction dependence and local-optimizer membership, keeps momentum on encoders, and synchronizes the shared prediction block to its current aggregate. Across KU-HAR, CREMA-D and other datasets under two fusion architectures, concatenation raises KU-HAR macro-F1 from 41.30 under the availability rule to 49.13, while under masked attention RASO leads on UCI-HAR, KU-HAR and CREMA-D and FedOpt leads on CrisisMMD.

  2. arXiv

    Heating control stops guessing from fixed thermometers: a time-free PINN holds room temperature fields within 1.85% error

    Indoor heating usually relies on one or a few fixed-point temperature readings, which miss the spatial variation around an occupant. A physics-informed neural network drops time as an explicit input and instead infers how the temperature field evolves from spatial coordinates plus a few sensor readings and their rates of change; across nine horizontal planes in three room-scale configurations it matched a validated COMSOL multiphysics simulation with a maximum relative error below 1.85%. Wired into occupant-centric heating control, it showed an average numerical error of about 0.67% against COMSOL-based offline control, with inference fast enough for real-time use.

  3. A 45-member modified Delphi consensus: screen for eating disorders before GLP-1 receptor agonist prescribing, and generally avoid these agents in active anorexia and bulimia nervosa

    Using a three-round modified Delphi method, a 45-member panel of clinicians and researchers in diabetes, obesity and/or eating disorders plus people with lived experience reached an average 91.7% consensus on recommendations for GLP-1 receptor agonist use in eating disorder contexts, covering pre-treatment screening, risk-stratified monitoring, standardized educational materials and concurrent evidence-based psychotherapy, stating that these agents should generally be avoided in active eating disorders, particularly anorexia nervosa, atypical anorexia nervosa and bulimia nervosa with marked dietary restraint and/or significant weight suppression, and setting out research priorities in epidemiology, regulation and binge eating disorder trials.

  4. Cancer

    CIBMTR real-world data: about one-third of multiple myeloma patients receiving cilta-cel are frail, with 12-month PFS of 62.7% and OS of 72.8% and doubled ICANS risk

    Using Center for International Blood and Marrow Transplant Research registry data, this study evaluated 541 patients with relapsed/refractory multiple myeloma who received commercial cilta-cel between March 2022 and December 2023 and found that 183 (33.8%) were frail by an adapted simplified frailty score; overall response rates were comparable (82.8% vs. 88.5%), but frail patients had worse 12-month progression-free survival (62.7% vs. 75.9%) and overall survival (72.8% vs. 90.4%) and more any-grade ICANS (32.2% vs. 17.6%), with frailty independently predicting worse PFS (HR 1.67), OS (HR 2.46), and any-grade ICANS (OR 2.01) on multivariable analysis.

  5. Journal of Asthma

    Feasibility of Assessing Clinical Remission in Asthma via a Customized Data Extraction Approach from a Real-World Clinical Electronic Medical Records Database in Japan: A Retrospective Real-World Study

    Using the Japanese JAMDAS electronic medical records database, this retrospective observational study analyzed 32,258 patients with asthma who initiated fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy between August 18, 2020 and December 31, 2024, extracting Asthma Control Test scores via structured query language and hospitalization and emergency transport data via a large language model, and assessed the proportion meeting the Japanese Practical Guidelines for Asthma Management 2024 clinical remission definition (oral corticosteroid-free, no exacerbations, ACT >= 23), treatment patterns, adherence and persistence at 3-month intervals up to 18 months; only 1.8-3.0%, 0.5-1.5% and 4.5-10.

You’re all caught up